Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90251-90300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04622150
Effectiveness RCT of Customized Adherence Enhancement
NAActive, not recruiting
190 participants
Started: Feb 1, 2022 · Completed: May 1, 2026
1 condition2 sponsors3 locations
NCT05072509
Assessment of the Endovascular Aortic Aneurysm Repair's (EVAR) Main Body Lateral Movement Impact on the Rate of Reintervention After AAA's Treatment
N/ANot yet recruiting
180 participants
Started: Feb 1, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT05999370
Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition
NARecruiting
60 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05187208
PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer
PHASE4Not yet recruiting
102 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
4 conditions5 sponsors0 locations
NCT05209737
Trendelenburg As a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients
NARecruiting
50 participants
Started: Jan 31, 2022 · Completed: Oct 20, 2026
2 conditions1 sponsor2 locations
NCT05034887
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
64 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2029
2 conditions2 sponsors1 location
NCT06844032
Predictors of Poor Prognosis in HFpEF
N/ARecruiting
400 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04899024
PrEP Affect Regulation Treatment Innovation
NAActive, not recruiting
239 participants
Started: Jan 31, 2022 · Completed: Jul 1, 2026
3 conditions3 sponsors2 locations
NCT04900493
The Rett Syndrome Global Registry
N/ARecruiting
5,000 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2031
1 condition7 sponsors1 location
NCT05162794
Is Laparoscopic Excision for Peritoneal Endometriosis Helpful or Harmful?
NARecruiting
100 participants
Started: Jan 31, 2022 · Completed: Jul 1, 2026
1 condition3 sponsors5 locations
NCT05287373
Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain
NAActive, not recruiting
89 participants
Started: Jan 31, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor5 locations
NCT05244889
Digital CBTI for Comorbid Insomnia in Chronic Migraine
NAActive, not recruiting
88 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2025
2 conditions1 sponsor2 locations
NCT05000242
West Hertfordshire Inflammatory Bowel Disease Technology Study
N/AActive, not recruiting
200 participants
Started: Jan 31, 2022 · Completed: Mar 1, 2024
1 condition2 sponsors1 location
NCT04149743
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
NARecruiting
420 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors2 locations
NCT05254353
Comparison of Different CSF Sampling Sites on External Ventricular Drains
N/ARecruiting
55 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04783428
Tumor-induced Osteomalacia Disease Monitoring Program
N/AActive, not recruiting
22 participants
Started: Jan 31, 2022 · Completed: Feb 28, 2032
1 condition1 sponsor6 locations
NCT05212155
RYSE Family-based Behavioral Treatment for Childhood Obesity
NAActive, not recruiting
108 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2024
1 condition4 sponsors2 locations
NCT05130632
Plastic Waste and Human Health Effects in Guatemala
NAActive, not recruiting
400 participants
Started: Jan 31, 2022 · Completed: May 30, 2026
1 condition5 sponsors2 locations
NCT05183854
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
PHASE2Recruiting
60 participants
Started: Jan 31, 2022 · Completed: Jan 7, 2028
2 conditions2 sponsors1 location
NCT05263037
EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain
NAActive, not recruiting
1,093 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05007470
Alcoholic Liver Disease and the Gut Microbiome
NAActive, not recruiting
80 participants
Started: Jan 31, 2022 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
N/AActive, not recruiting
72 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2027
7 conditions1 sponsor6 locations
NCT05203445
A Study of Olaparib and Pembrolizumab in People with Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
PHASE2Active, not recruiting
23 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors7 locations
NCT05215197
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
NARecruiting
10 participants
Started: Jan 31, 2022 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT05114785
Heart Failure With Preserved Ejection Fraction: Evaluation and Recognition by CMR
N/ANot yet recruiting
100 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2032
2 conditions2 sponsors0 locations
NCT05136235
Pulmonary Hypertension in Extremely Preterm Infants
NANot yet recruiting
350 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
3 conditions7 sponsors0 locations
NCT05136079
Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies
PHASE3Not yet recruiting
40 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05160636
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
N/AActive, not recruiting
999 participants
Started: Jan 31, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT05153941
Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures
N/AActive, not recruiting
3,500 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2030
2 conditions3 sponsors1 location
NCT06514287
Telehealth Interventions for Daily Routine Activities in Children and Adolescents With Disabilities
NAActive, not recruiting
21 participants
Started: Jan 31, 2022 · Completed: Oct 25, 2024
2 conditions1 sponsor1 location
NCT05150691
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
796 participants
Started: Jan 31, 2022 · Completed: Oct 31, 2027
1 condition2 sponsors102 locations
NCT05228145
Gene Therapy Study for Children With CLN5 Batten Disease
PHASE1/PHASE2Active, not recruiting
6 participants
Started: Jan 31, 2022 · Completed: Nov 30, 2028
1 condition1 sponsor2 locations
NCT05241951
Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities
NAActive, not recruiting
5,760 participants
Started: Jan 31, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT06951087
Intravitreal and Intracameral DEX in NPDR
PHASE3Enrolling by invitation
80 participants
Started: Jan 31, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04455932
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NARecruiting
476 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor10 locations
NCT05989243
Improving Socket Fit in Female and Male Veterans With Transtibial and Transfemoral Amputation
N/ARecruiting
40 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05185869
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
PHASE2Not yet recruiting
58 participants
Started: Jan 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06337669
Characterization of DupEx2 Duchenne Muscular Dystrophy
N/ARecruiting
26 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05162898
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
NANot yet recruiting
90 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05199389
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy
NAActive, not recruiting
60 participants
Started: Jan 31, 2022 · Completed: Nov 10, 2028
1 condition1 sponsor1 location
NCT04779762
"Stelara and Diet Trial for Crohns Disease"
NANot yet recruiting
40 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT04054934
Influence of Circadian Clock on Hormonal, Metabolic, Neurocognitive Markers in Adolescents With and Without Diabetes
N/ANot yet recruiting
100 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2026
4 conditions3 sponsors0 locations
NCT05532059
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
PHASE2Recruiting
100 participants
Started: Jan 31, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT04227314
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
PHASE3Not yet recruiting
134 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT06404164
Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
NARecruiting
3,000 participants
Started: Jan 30, 2022 · Completed: Dec 30, 2027
3 conditions1 sponsor1 location
NCT06851403
The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study
N/AEnrolling by invitation
213 participants
Started: Jan 30, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05176223
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
PHASE2Active, not recruiting
30 participants
Started: Jan 30, 2022 · Completed: Nov 30, 2027
4 conditions1 sponsor1 location
NCT05195658
Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)
N/ARecruiting
20 participants
Started: Jan 30, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06417710
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
N/ARecruiting
200 participants
Started: Jan 30, 2022 · Completed: Dec 31, 2026
4 conditions3 sponsors3 locations
NCT06222008
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
N/ARecruiting
40 participants
Started: Jan 30, 2022 · Completed: Jun 30, 2024
3 conditions1 sponsor1 location